Avastin challenges Lucentis dominance in wet AMD

Avastin challenges Lucentis dominance in wet AMD

Posted on 26th April 2012

The leading wet AMD treatment used in the NHS, Lucentis, is under pressure from a cheaper version called Avastin.

Both compounds are from the family of AntiVEGF drugs (anti-vascular endothelial growth factor). In wet AMD, the degeneration causes the retina to make tiny new blood vessels in response to damage. These blood vessels are very fragile and break and bleed into the retina causing scarring and eventually vision loss.

AntiVEGF drugs stop and even shrink the growth of these new blood vessels preventing the damaging bleeding. Until now Lucentis has been the only approved drug for use in the eye and costs over £700 per injection (used in multiples of 3 injections normally). Avastin is in the same family of drugs and currently used to treat heart conditions. Costing only £60 per injection, many specialists in other countries have been using it ‘off label’ in the eye to great effect.

Avastin is now being used to treat 50% of AMD cases in the US and there is increasing pressure on the NHS to approve the use of this drug enabling far more access to the sight saving treatment.

At Cameron Optometry, we’re experts in all forms of macular disease and have the latest OCT technology which is used by specialists to diagnose and monitor the effects of treatment on wet AMD. If you are concerned or have a family history of the condition, come and see us for some expert advice.


Related Posts

Standards of vision for driving

22nd November 2016

It is essential that you check your vision regularly to ensure you are fit to drive. A recent study found that a worrying one in eight drivers who knew they need glasses or contact lenses to drive, ha...

Read more

BBig appealing, exciting, daring, stylish and (almost) indestructible! Our new range of frames for kids

16th November 2016

Children often miss out when it comes to stylish glasses. The options for adults are endless, however for kids it usually comes down to character or basic metal frames. With this in mind, we went on t...

Read more

Cameron Optometry only practice with three independent prescribing optometrists

11th November 2016

We are delighted to announce that Claire Keith has become our third independent prescriber, having graduated today. After three years of study, Claire joins fellow optometrists Ian Cameron and Gillian...

Read more

Blue light: is it harming my vision?

20th October 2016

What is it and why is it important? The visible light that our eyes can see is composed of a spectrum of colours, just like a rainbow. Sunlight consists of the entire spectrum of light so we are ex...

Read more